Search results

Filters

  • Journals
  • Authors
  • Keywords
  • Date
  • Type

Search results

Number of results: 3
items per page: 25 50 75
Sort by:
Download PDF Download RIS Download Bibtex

Abstract

In 46 dogs with congenital portosystemic shunt (cPSS) histopathological examination of the pancreas, including measuring of the islet area, was performed, and the results were compared with those obtained in 6 control dogs without cPSS. Pancreatic islets were found in 43 (94%) dogs with cPSS and in all control animals. Mean area of the pancreatic islets was significantly lower in cPSS patients (median of 2219.4 μm2, interquartile range [IQR] from 1559.0 to 3146.2 μm2, range from 485.4 to 10333.4 μm2) than in control dogs (median of 8705.5 μm2, IQR from 8284.4 to 9329.2 μm2, range from 7689.9 to 9624.2 μm2) (p<0.001). The area of pancreatic islets was weakly, but significantly, positively correlated with the body weight of dogs (r=0.32, p=0.026), but not with the age or sex. Vacuoles were found in the cytoplasm of pancreatic islet cells in 37 (87%) dogs with cPSS and in none of the control animals (p<0.001). Their presence was not linked to the sex, breed, age or body weight. Extracellular homogenous eosinophilic masses were present in pancreatic islets in 5 (12%) cPSS patients and in none of control animals. Connective tissue hyperplasia was found in pancreatic islets of 4 (9%) dogs with cPSS and in none of the control dogs. These results indicate that cPSS severely affects the pancreas, as shown by significantly reduced area of the islets, and the presence of eosinophilic masses in the pancreas and/or intracellular vacuoles.
Go to article

Bibliography


Baade S, Aupperle H, Grevel V, Schoon HA (2006) Histopathological and immunohistochemical investigations of hepatic lesions associated with congenital portosystemic shunt in dogs. J Comp Pathol 134: 80-90.

Collings AJ, Gow AG, Marques A, Yool D, Furneaux R, Mellanby R, Watson PJ (2012) A prospective study of basal insulin concentrations in dogs with congenital portosystemic shunts. J Small Anim Pract 53: 228-233.

Cui W, Cui H, Peng X, Fang J, Zuo Z, Liu X, Wu B (2011) Changes of relative weight and cell cycle, and lesions of bursa of Fabricius in-duced by dietary excess vanadium in broilers. Biol Trace Elem Res 143: 251-260.

Frymus J, Trębacz P, Degórska B, Sterna J, Kowalczyk P, Tomkowicz A, Galanty M (2015) Portosystemic shunt in dogs and cats. Current diagnostic aspects. Magazyn Wet 24: 12-22

Frymus J, Trębacz P, Sobczak-Filipiak M, Czopowicz M, Degórska B, Galanty M (2020) Histopathological picture of pancreatic islets in dogs with congenital portosystemic shunt. Med Weter 76: 103-106.

Gow AG (2017) Hepatic encephalopathy. Vet Clin North Am Small Anim Pract 47: 585-599.

Kikumoto Y, Sugiyama H, Inoue T, Morinaga H, Takiue K, Kitagawa M, Fukuoka N, Saeki M, Maeshima Y, Wang DH, Ogino K, Masuoka N, Makino H (2010) Sensitization to alloxan-induced diabetes and pancreatic cell apoptosis in acatalasemic mice. Biochim Biophys Acta 1802: 240-246.

Kraun MB, Nelson LL, Hauptman JG, Nelson NC (2014) Analysis of the relationship of extrahepatic portosystemic shunt morphology with clinical variables in dogs: 53 cases (2009-2012). J Am Vet Med Assoc 245: 540-549.

Majd N E, Tabandeh MR, Shahriari A, Soleimani Z (2018) Okra (Abelmoscus esculentus) improved islets structure, and down-regulated PPARs gene expression in pancreas of high-fat diet and streptozotocin-induced diabetic rats. Cell J 20: 31-40.

Mankin KM (2015) Current concepts in congenital portosystemic shunts. Vet Clin North Am Small Anim Pract 45: 477-487.

Masjedi F, Gol A, Dabiri S (2013) Preventive effect of garlic (Allium sativum L.) on serum biochemical factors and histopathology of pan-creas and liver in streptozotocin-induced diabetic rats. Iran J Pharm Res 12: 325-338.

Morandi F, Sura PA, Sharp D, Daniel GB (2010) Characterization of multiple acquired portosystemic shunts using transplenic portal scintig-raphy. Vet Radiol Ultrasound 51: 466-471.

Muranishi T, Takehana K, Hiratsuka T, Kobayashi A, Eerdunchaolu, Iwasa K, Abe M (1999) An investigation of the relationship between duct system and A cell-rich and PP cell-rich pancreatic islets in the canine pancreas. J Vet Med Sci 61: 737-742.

Noda K, Melhorn MI, Zandi S, Frimmel S, Tayyari F, Hisatomi T, Almulki L, Pronczuk A, Hayes KC, Hafezi-Moghadam A (2010) An animal model of spontaneous metabolic syndrome: Nile grass rat. FASEB J 24: 2443-2453.

Perazzo JC, Tallis S, Delfante A, Souto PA, Lemberg A, Eizayaga FX, Romay S (2012) Hepatic encephalopathy: an approach to its multiple pathophysiological features. World J Hepathol 4: 50–65.

Przybylik-Mazurek E, Pach D, Hubalewska-Dydejczyk A, Sowa-Staszczak A, Gilis-Januszewska A, Kulig J, Matyja A, Chrapczyński P (2012) Symptoms and early diagnostic possibilities of pancreatic endocrine cells hyperplasia (nesidioblastosis). Przegląd Lekarski 69: 9-14.

Raffel A, Krausch MM, Anlauf M, Wieben D, Braunstein S, Klöppel G, Röher HD, Knoefel WT (2007) Diffuse nesidioblastosis as a cause of hyperinsulinemic, hypoglycemia in adults: a diagnostic and therapeutic challenge. Surgery 141: 179-184.

Sobczak-Filipiak M, Szarek J, Czopowicz M, Galanty M, Dolka I, Trębacz P, Frymus J, Lechowski R (2018a) Stellate cells in livers of dogs with portal vein hypoperfusion. Med Weter 74: 392–397

Sobczak-Filipiak M, Męcik-Kronenberg T, Czopowicz M, Galanty M, Trębacz P, Frymus J, Badurek I, Szarek J (2018b) Lipogranulomas and pigment granulomas in livers of dogs with portosystemic shunt. Pol J Vet Sci 21: 265-272.

Sobczak-Filipiak M, Szarek J, Badurek I, Padmanabhan J, Trębacz P, Januchta-Kurmin M, Galanty M (2019) Retrospective Liver Histomor-phological Analysis in Dogs in Instances of Clinical Suspicion of Congenital Portosystemic Shunt. J Vet Res;63: 243-249.

Tivers MS, Handel I, Gow AG, Lipscomb VJ, Jalan R, Mellanby RJ (2014) Hyperammonemia and systemic inflammatory response syn-drome predicts presence of hepatic encephalopathy in dogs with congenital portosystemic shunts. PLoS One 9: e82303.

Tobias KM, Rohrbach BW (2003) Association of breed with the diagnosis of congenital portosystemic shunts in dogs: 2,400 cases (1980-2002). J Am Vet Med Assoc 223: 1636-1639.

Yabe K, Yamamoto Y, Suzuki T, Takada S, Mori K (2019) Functional and morphological characteristics of pancreatic islet lesions induced by quinolone antimicrobial agent gatifloxacin in rats. Toxicol Pathol 47: 35-43.

Zhang B, Li SS, Men JL, Zhang ZH (2018) Effect of long-term crotonaldehyde exposure on heart damage in male rats. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 36: 647-652
Go to article

Authors and Affiliations

J. Frymus
1
P. Trębacz
1
M. Sobczak-Filipiak
2
M. Czopowicz
3
M. Galanty
1

  1. Department of Small Animal Diseases with Clinic, Warsaw University of Life Sciences – SGGW, Nowoursynowska 159c, 02-776 Warszawa, Poland
  2. Department of Pathology and Veterinary Diagnostics, Warsaw University of Life Sciences – SGGW, Nowoursynowska 159c, 02-776 Warszawa, Poland
  3. Division of Veterinary Epidemiology and Economics, Institute of Veterinary Medicine, Warsaw University of Life Sciences – SGGW, Nowoursynowska 159c, 02-776 Warszawa, Poland
Download PDF Download RIS Download Bibtex

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is characterized by very poor prognosis. It is caused by asymptomatic course of the disease at early stage. Symptomatic PDAC means usually advanced stage of the disease, making radical treatment impossible. Finding of biological PDAC marker could improve PDAC treatment through early diagnosis. In our study, we investigated two adipokines: omentin and chemerin concentration in PDAC, chronic pancreatitis (CP) and healthy individuals. We examined 27 PDAC patients, 10 CP patients and 36 controls. To determine concentration of adipokines we used ELISA immunoenzymatic assay. Level of both adipokines was increased when comparing control group to PDAC patients. Additionally, chemerin concentration in CP group was elevated comparing to control. To evaluate both adipokines as potential PDAC biomarkers we performed ROC analysis. Chemerin (AUC = 0.913) displayed better discriminant ability than omentin-1 (AUC = 0.73). Some authors believe that chemerin may promote tumour growth by stimulating angiogenesis and is supposed to be a factor recruiting mesenchymal stroma cells (MSC) in tumour regions. Omentin-1 can inhibit tumourigenesis by TP53 stimulation. On the other hand, according to some studies, omentin-1 may promote cancer proliferation via Akt signalling pathway. Results from our study showed signifi cantly elevated level of chemerin and omentin-1 in PDAC patients. Th erefore, w e believe that both investigated adipokines may provide promising and novel pharmacological insights for oncological diagnosis in the near future.

Go to article

Authors and Affiliations

Paweł Kiczmer
Błażej Szydło
Alicja Prawdzic Seńkowska
Janusz Jopek
Maciej Wiewióra
Jerzy Piecuch
Zofia Ostrowska
Elżbieta Świętochowska
Download PDF Download RIS Download Bibtex

Abstract

Background: Despite advanced research and great progress in understanding the chronic pancreatitis (CP) pathogenesis, no current causal treatment for the condition is available. For preclinical studies, the existence of a well-characterized CP animal model is essential.
The aim of the study was to assess the impact of chronic pancreatitis on the antioxidant enzymes activity in rat blood serum and on the level of glutathione (intracellular antioxidant) in rat pancreas.
Methods: The experiments were carried out on the Wistar Kyoto rats in two groups: control and study group (CP), in which chemical induction of pancreatitis with dibutyl dichloride was performed. Serum enzyme activities of amylase, lipase, catalase and superoxide dismutase were analyzed. The levels of the following biochemical parameters were also investigated: total protein, albumin, calcium, magnesium, and triglycerides. Levels of low-molecular-weight thiols: reduced (GSH) and oxidized (GSSG) glutathione, were determined in pancreatic homogenates.
Results: Histopathological imaging of rat pancreatic parenchyma with induced inflammation confirmed focal lymphocytic interstitial chronic pancreatitis with fibrosis features and mild parenchymal atrophy, as well as pancreatic islets degeneration. In the CP group, we observed a statistically significant decrease in serum amylase and lipase activities and in total protein/albumin levels. Also, the elevated catalase activity was registered. In CP rats’ tissues, we observed a 15-fold reduction in GSH levels. The other examined parameters remained unchanged. Clinically relevant are hypoalbuminemia and a moderate decrease in lipase activity. The described changes are most probably indicative of the impaired exocrine pancreas function, however without organ failure features.
Go to article

Authors and Affiliations

Patrycja Bronowicka-Adamska
1
Tomasz Hutsch
2
Dominika Szlęzak
1
Anna Bentke-Imiolek
1
Kinga Kaszuba
1
Piotr Ceranowicz
3
Beata Kuśnierz-Cabala
1

  1. Chair of Medical Biochemistry, Faculty of Medicine, Jagiellonian University Medical College, Kraków, Poland
  2. Department of Pathology and Veterinary Diagnostics, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Warsaw, Poland
  3. Department of Physiology, Faculty of Medicine, Jagiellonian University Medical College, Kraków, Poland

This page uses 'cookies'. Learn more